77
Views
39
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

First Identification of blaOXA-51-like in Non-baumannii Acinetobacter spp.

Pages 514-520 | Published online: 18 Jul 2013

REFERENCES

  • Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemio-logical features. Clin Microbiol Rev 1996; 9 (2): 148–65.
  • Poiret L, Nordmann P. Carbapenem resistance in Acine-tobacter baumannii: mechanisms and epidemiology. Clin Mi-crobiol Infect 2006; 12 (9): 826–36.
  • Heritier C, Poiret L, Fournier PE, Claverie JM, Raoult D, Nordmann P. Characterization of the naturally occurring oxacil-linase of Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49 (10): 4174–9.
  • Merkier AK, Centron D. bla(OXA-51)-type beta-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii. Int J Antimicrob Agents 2006; 28 (2): 110–3.
  • Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaox„,, carbapenemase gene intrinsic to this species. J Clin Microbiol 2006; 44 (8): 2974–6.
  • Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM et al. The role of ISAbal in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Mi-crobiol Lett 2006; 258 (1): 72-7.
  • Chen TL, Siu LK, Wu RC, Shaio MF, Huang LY, Fung CP et al. Comparison of one-tube multiplex PCR, automated ribo-typing and intergenic spacer (ITS) sequencing for rapid identifi-cation of Acinetobacter baumannii. Clin Microbiol Infect 2007; 13 (8): 801-6.
  • SChang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, Chang TC. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 2005; 43 (4): 1632–9.
  • lbrahim A, Gerner-Smidt P, Liesack W. Phylogenetic rela-tionship of the twenty-one DNA groups of the genus Acineto-bacter as revealed by 16S ribosomal DNA sequence analysis. Int J Syst Bacteriol 1997; 47 (3): 837–41.
  • Vaneechoutte M, Dijkshoorn L, Tjernberg I, Elaichouni A, de Vos P, Claeys G et al. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol 1995; 33 (1): 11-5.
  • La Scola B, Gundi VA, Khamis A, Raoult D. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol 2006; 44 (3): 827–32.
  • Higgins PG, Wisplinghoff H, Krut O, Seifert H. A PCR-based method to differentiate between Acinetobacter bauman-nii and Acinetobacter genomic species 13TU. Clin Microbiol Infect 2007; 13 (12): 1199–201.
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth in-formational supplement. M100-519. Wayne, PA: CLSI; 2009.
  • Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27 (4): 351-3.
  • Poiret L, Nordmann P. Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacil-linase gene bla0A_58 in Acinetobacter baumannii. Antimicrob Agents Chemother 2006; 50 (4): 1442–8.
  • Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amico-sante G, Fontana R et al. Cloning and characterization of blavim,a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 1999; 43 (7): 1584-90.
  • Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H et al. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 1994; 38 (1): 71-8.
  • Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD et al. Characterization of VIM-2, a carbapenem-hydrolyzing me-tallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. An-timicrob Agents Chemother 2000; 44 (4): 891-7.
  • Pasteran F, Rapoport M, Petroni A, Faccone D, Corso A, Galas M et al. Emergence of PER-2 and VEB-la in Acinetobac-ter baumannii Strains in the Americas. Antimicrob Agents Chemother 2006; 50 (9): 3222-4.
  • Castanheira M, Toleman MA, Jones RN, Schmidt FJ, Walsh TR. Molecular characterization of a beta-lactamase gene, blaGm_i, encoding a new subclass of metallo-beta-lactamase. An-timicrob Agents Chemother 2004; 48 (12): 4654–61.
  • Franklin C, Liolios L, Peleg AY. Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory. J Clin Microbiol 2006; 44 (9): 3139–44.
  • L K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003; 41 (10): 4623-9.
  • Lola K, Rice TW, Munoz-Price LS, Quinn JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii iso-lates producing the carbapenemase OXA-40. Antimicrob Agents Chemother 2006; 50 (9): 2941–5.
  • Sambrook J, Russel DW. Molecular Cloning: A Laboratory Manual, 3rd ed. Cold Spring Harbor, NY: Cold Spring Har-bor Laboratory Press. 2001.
  • Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN. Emergence and widespread dissemination of OXA-23, - 24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother 2009; 63 (1): 55–9.
  • Wang H, Guo P, Sun H, Wang H, Yang Q, Chen M et al. Molecular epidemiology of clinical isolates of carbapenem-resis-tant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother 2007; 51 (11): 4022-8.
  • Poiret L, Marque S, Heritier C, Segonds C, Chabanon G, Nordmann P. OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. An-timicrob Agents Chemother 2005; 49 (1): 202–8.
  • Marti S, Sanchez-Cespedes J, Blasco MD, Espinal P, Ruiz M, Alba V et al. Characterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an Acinetobacter phenon 6/ctl3TU clinical isolate. Diagn Microbiol Infect Dis 2008; 61 (4): 468-70.
  • Poirel L, Figueiredo S, Cattoir V, Carattoli A, Nordmann P. Acinetobacter radioresistens as a silent source of car-bapenem resistance for Acinetobacter spp. Antimicrob Agents Chemother 2008; 52 (4): 1252–6.
  • Hu WS, Yao SM, Fung CP, Hsieh YP, Liu CP, Lin JF. An OXA-66/0XA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acineto-bacter baumannii. Antimicrob Agents Chemother 2007; 51 (11): 3844–52.
  • Ruiz M, Marti S, Fernandez-Cuenca F, Pascual A, Vila J. High prevalence of carbapenem-hydrolysing oxacillinases in epi-demiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect 2007; 13 (12): 1192–8.
  • Segal H, Gamy S, Elisha BG. Is I5ABA4 customized for Acinetobacter? FEMS Microbiol Lett 2005; 243 (2): 425-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.